Exenatide ER did not significantly reduce weight compared to placebo in 84 adolescents with T2DM, previously treated with diet and exercise alone or with metformin ± a sulfonylurea and/or insulin after 24 and 52 weeks (45, 46). This evidence concerns the gene INS and type 2 diabetes mellitus.